nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant Radiotherapy in Stage II Endometrial Cancer: Selective De-intensification of Adjuvant Treatment
|
Paulson, K. |
|
|
35 |
1 |
p. e94-e102 |
artikel |
2 |
A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts
|
Xu, H. |
|
|
35 |
1 |
p. e48-e59 |
artikel |
3 |
A New Approach to Quantify and Grade Radiation Dermatitis Using Deep-Learning Segmentation in Skin Photographs
|
Park, Y.I. |
|
|
35 |
1 |
p. e10-e19 |
artikel |
4 |
A Novel Prognostication System for Spinal Metastasis Patients Based on Network Science and Correlation Analysis
|
Mezei, T. |
|
|
35 |
1 |
p. e20-e29 |
artikel |
5 |
An Update to the Malthus Model for Radiotherapy Utilisation in England
|
Heritage, S. |
|
|
35 |
1 |
p. e1-e9 |
artikel |
6 |
Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer – Real-World Outcomes From UK Centres
|
Lorimer, C. |
|
|
35 |
1 |
p. e60-e66 |
artikel |
7 |
Further Considerations in Regards to Commissioning of Spine Stereotactic Ablative Body Radiotherapy
|
Barker, C.L. |
|
|
35 |
1 |
p. e103 |
artikel |
8 |
Guidelines on the Use of Systemic Therapy in Patients with Advanced Thyroid Cancer
|
Wadsley, J. |
|
|
35 |
1 |
p. 57-64 |
artikel |
9 |
Hypofractionated or Conventionally Fractionated Adjuvant Radiotherapy After Regional Lymph Node Dissection for High-Risk Stage III Melanoma
|
Holtkamp, L.H.J. |
|
|
35 |
1 |
p. e85-e93 |
artikel |
10 |
Integrating Novel Cancer Therapies with Radiation – Illuminating the Tunnel
|
O'Cathail, S.M. |
|
|
35 |
1 |
p. 38-41 |
artikel |
11 |
Lacrimal Carcinoma Ex Pleomorphic Adenoma: A Population-based Study
|
Loap, P. |
|
|
35 |
1 |
p. 65-67 |
artikel |
12 |
Launch of the UK SABR Consortium Pelvic Stereotactic Ablative Radiotherapy Re-irradiation Guidelines and National Audit
|
Muirhead, R. |
|
|
35 |
1 |
p. 29-32 |
artikel |
13 |
Leaders, qui sequuntur te?
|
Ajithkumar, T.V. |
|
|
35 |
1 |
p. 1-2 |
artikel |
14 |
Nature versus Nurture: what Underpins Great Leadership?
|
Hoskin, P. |
|
|
35 |
1 |
p. 10-11 |
artikel |
15 |
Nature Versus Nurture: What Underpins Great Leadership? The Case for Nurture
|
Turner, S. |
|
|
35 |
1 |
p. 6-9 |
artikel |
16 |
OncoFlash January 2023
|
Crockett, C. |
|
|
35 |
1 |
p. 3-5 |
artikel |
17 |
Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK
|
Wadsley, J. |
|
|
35 |
1 |
p. 42-56 |
artikel |
18 |
RCR Meetings
|
|
|
|
35 |
1 |
p. I |
artikel |
19 |
Real World Data – Does it Cut the Mustard or Should We Take it With a Pinch of Salt?
|
Muirhead, R. |
|
|
35 |
1 |
p. 15-19 |
artikel |
20 |
Severity of Dementia and Survival in Patients Diagnosed with Colorectal Cancer: A National Cohort Study in England and Wales
|
Kuryba, A.J. |
|
|
35 |
1 |
p. e67-e76 |
artikel |
21 |
Stereotactic Body Radiotherapy for Painful Spinal Metastases - A Significant Advance in the Field of Radiation Oncology
|
Dunne, E.M. |
|
|
35 |
1 |
p. e104-e105 |
artikel |
22 |
Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes
|
Glicksman, R.M. |
|
|
35 |
1 |
p. 20-28 |
artikel |
23 |
TARGET National: A UK-wide Liquid-based Molecular Profiling Programme
|
Ortega-Franco, A. |
|
|
35 |
1 |
p. 33-37 |
artikel |
24 |
The Metaverse and Oncology
|
McWilliam, A. |
|
|
35 |
1 |
p. 12-14 |
artikel |
25 |
Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer Patients
|
Flammia, R.S. |
|
|
35 |
1 |
p. e77-e84 |
artikel |
26 |
Vestibular Schwannoma Hypofractionated Stereotactic Radiation Therapy in Five Fractions
|
Gawish, A. |
|
|
35 |
1 |
p. e40-e47 |
artikel |
27 |
Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study
|
Deodato, F. |
|
|
35 |
1 |
p. e30-e39 |
artikel |